Oncology Letters · 2020 · 81 citations · 24 references
MedicineOncologyPathologyMetastasisMolecular OncologyOncogenesBreast Cancer RecurrenceBreast PathologyCancer BiomarkersCancer Cell SignalingLymph Node MetastasisTumor MarkersLymph Node Metastasis BiomarkersLymph Node Metastasis PrognosisMapk SignalingMitogen-activated Protein Kinase KinaseProtein Expression LevelsTriple-negative Breast Cancer RecurrenceTumor Depth Of InvasionTumor Invasion Assessment
To investigate the expression and clinical significance of mitogen‑activated protein kinase (MAPK) and epidermal growth factor receptor (EGFR) in triple‑negative breast cancer (TNBC), a total of 300 TNBC and 120 paired paracancerous tissues were examined. Immunohistochemistry was conducted to determine the expression levels of MAPK and EGFR, and the correlation between MAPK and EGFR expression was evaluated using Cramer's V test. The association between MAPK and EGFR expression, and various clinicopathological variables (such as lymph node metastasis, clinical stage, recurrence and metastasis) was also evaluated, using the χ2 test. MAPK and EGFR expression levels in TNBC tissues were significantly higher than in the paired paracancerous tissues. Moreover, MAPK expression was associated with that of EGFR in TNBC tissues. The positive expression rates of MAPK and EGFR in patients with lymph node metastasis, advanced clinical stage, tumor recurrence and metastasis were higher than those without. Patients with positive expression of MAPK and EGFR in TNBC tissues had poorer prognoses and lower overall survival times than those without expression. In summary, the expression of MAPK and EGFR is closely associated with tumor invasion and the metastasis of TNBC, and may therefore be used as an indicator of poor prognosis in patients with TNBC.
24
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah, Andrew Roth, Rodrigo Goya et al. · Nature · 2012 · 2K citations
Prognostic markers in triple‐negative breast cancer
Emad A. Rakha, Maysa E. El‐Sayed, Andrew R. Green et al. · Cancer · 2006 · 1.3K citations
Medicine, Oncology, Breast Oncology +16
William M. Sikov, Donald A. Berry, Charles M. Perou et al. · Journal of Clinical Oncology · 2014 · 1K citations · Full text
Medicine, Oncology, Pharmacology +17
Triple-negative breast cancer: treatment challenges and solutions
Guy Jérusalem, Joëlle Collignon, Hélène Schroeder et al. · Breast Cancer Targets and Therapy · 2016 · 383 citations · Full text
Medicine, Oncology, Pharmacology +17
Hyperactivation of MAPK Induces Loss of ERα Expression in Breast Cancer Cells
Annabell S. Oh, Lori A. Lorant, Jamie N. Holloway et al. · Molecular Endocrinology · 2001 · 227 citations · Full text